Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of ...

BURLINGTON, Mass., June 06, 2025--(BUSINESS WIRE)--Bone Biologics Corporation ("Bone Biologics" or the "Company") (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, ...

(RTTNews) - Bone Biologics Corporation (BBLG) has announced a 1-for-6 reverse stock split of its common stock, which will take effect at 12:01 a.m. ET on Tuesday, June 10, 2025. The company's shares ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces that a 1-for-30 reverse stock split became ...